Edwards Lifesciences Corp (EW) Valuation & Financial Model
Interactive Discounted Cash Flow (DCF) model for Edwards Lifesciences Corp (US:EW), trading at 86.92. In 2025, Edwards Lifesciences Corp generated $6.07 Billion in revenue and $1.33 Billion in free cash flow. Explore projected intrinsic value assumptions based on institutional-grade macro metrics.
Valuation Methodology & Recent Performance
The financial model for Edwards Lifesciences Corp is calculated using an institutional discounted cash flow (DCF) engine utilizing recent operational metrics:
- Current Price: 86.92
- Recent Revenue (2025): $6.07 Billion
- Free Cash Flow (2025): $1.33 Billion
- Discount Rate (WACC): Derived using the Risk-Free Rate (e.g., 10Y Gov Bond) plus an Equity Risk Premium based on market volatility and stock price variance.
- Terminal Value: Projected using a perpetual growth model bounded by long-term macroeconomic estimates.